Publications

Project

Exploring the modification of sample size in Phase I trials using the continual reassessment method on proof-of-concept during drug development

Thomann MA, Foster ED, Coffey CS

Applied Stochastic Models and Data Analysis International Conferences, Meetings and Publications. 2016;

How Stable are Parkinson’s Disease Subtypes in De Novo Patients: Analysis of the PPMI Cohort

Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, & Marek K on behalf of the PPMI Investigators

Parkinsonism & Related Disorders. 2016; 28 62-67.

PubMed:

27132498

Motor and Nonmotor Heterogeneity of LRRK2-Related and Idiopathic Parkinson’s Disease

Marras C, Alcalay RN, Caspell-Garcia C, Coffey C, Chan P, Duda JE, Facheris MF, FernandezSantiago R, Ruiz-Martinez J, Mestre T, Saunders-Pullman R, Pont-Sunyer C, Tolosa E, & Waro B on behalf of the LRRK2 Cohort Consortium

Movement Disorders. 2016; 31 (8) 1192-1202.

PubMed:

27091104

Physician-Pharmacist Collaboration versus Usual Care for Treatment-Resistant Hypertension

Smith SM, Carris NW, Dietrich E, Gums JG, Uribe L, Coffey C, Gums TH, & Carter BL

Journal of the American Society for Hypertension. 2016; 10 (4) 307-317.

PubMed:

PMC4829453

Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap

Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, & Carter BL

Hypertension. 2016; 68 (5) 1314-1320.

PubMed:

PMC5063695

Predictors of Time to Initiation of Symptomatic Therapy in Early Parkinson’s Disease

Simuni T, Long JD, Caspell-Garcia C, Coffey CS, Lasch S, Tanner CM, Jennings D, Kieburtz KD, & Marek K on behalf of the PPMI Investigators

Annals of Clinical and Translational Neurology. 2016; 3 (7) 482-494.

PubMed:

PMC4931714

Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection

Lyden P, Weymer S, Coffey C, Cudkowicz M, Berg S, O’Brien S, Fisher M, Haley EC, Khatri P, Saver J, Levine S, Levy H, Rymer M, Wechsler L, Jadhav A, McNeil E, Waddy S, and Pryor K

Stroke. 2016; 47 (12) 2979-2985.

PubMed:

PMC5134840

The Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Report on Baseline Characteristics of Participants

Powers SW, Hershey AD, Coffey CS, Chamberlin LA, Ecklund DJ, Sullivan SM, Klingner EA, Yankey JW, Kashikar-Zuck S, Korbee LL, Costigan ML, Riss HH, & Porter LL

Headache. 2016; 56 (5) 859-870.

PubMed:

PMC5050048

Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control

Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vader Weg M, Chrischilles E, Vaught T.

Circulation, Cardiovascular Quality and Outcomes. 2015 May; 8 (3) 235-43.

PubMed:

PMC4618490

A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence

Carter BL, Coffey CS, Chrischilles EA, Ardery G, Ecklund D, Gryzlak B, Vander Weg MW, James PA, Christensen AJ, Parker CP, Gums T, Finkelstein RJ, Uribe L, Polgreen LA, MEDication Focused Outpatient Care for Underutilization of Secondary Prevention Trial Investigators

Pharmacotherapy. 2015 Jul; 35 (7) 653-62.

PubMed:

PMC4686257

You are here

Publications